Tyra Biosciences, Inc. (TYRA) Operating cash flow 2020–2025
Tyra Biosciences, Inc. (TYRA) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$95.1MFY2025 · since FY2020: -$7.8M → -$95.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$95.1M | -36.4% |
| FY2024 | -$69.8M | -39.2% |
| FY2023 | -$50.1M | +0.3% |
| FY2022 | -$50.3M | -111.8% |
| FY2021 | -$23.7M | -205.9% |
| FY2020 | -$7.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More TYRA financial trends
TYRA RevenueTYRA Net incomeTYRA Net marginTYRA Gross profitTYRA Gross marginTYRA Operating incomeTYRA Operating marginTYRA Free cash flowTYRA Capital expendituresTYRA Return on equityTYRA Stock buybacksTYRA Dividends paidTYRA Total assetsTYRA Total liabilitiesTYRA Shareholders’ equityTYRA overview →